C&C Biotech Pharmaceuticals

C&C Biotech Pharmaceuticals is a joint venture between US-based R&D partners and Asian distribution partners, established in 1999. The company specializes in aging biology, particularly sirtuin protein research, with advanced capabilities in phytochemistry, pharmacokinetics, formulation development, pre-clinical studies, and some clinical work. Their laboratory has been approved for in-house research by the US Ministry of Science & Technology. They collaborate internationally with universities from Australia, China, Taiwan, and Japan. No published late-stage clinical results or commercialized drugs were identified as of June 2025.